Behavioral Therapy for Cornelia de Lange Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on helping children with Cornelia de Lange syndrome (CdLS) who exhibit problem behaviors, such as aggression or self-injury. Researchers aim to identify the triggers of these behaviors and develop a treatment model to reduce them. The trial uses a special behavioral therapy called ABA-based functional analysis and treatment (Applied Behavior Analysis) to assess and address these issues. Children aged 3 to 15 with CdLS and frequent problem behaviors may qualify if their parents can attend clinic visits and implement a behavior plan at home. Families of children with CdLS who do not exhibit problem behaviors can also participate by providing regular updates for two years. As an unphased trial, this study offers families the chance to contribute to groundbreaking research that could improve the lives of children with CdLS.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this behavioral therapy is safe for children with Cornelia de Lange Syndrome?
Research has shown that Applied Behavior Analysis (ABA) treatments are generally safe and well-tolerated. Studies have found that ABA effectively reduces problem behaviors in children. A review of research found that trial-based functional analyses, a component of ABA, can safely help manage challenging behaviors. Additionally, a retrospective study showed that when parents led ABA interventions, children experienced positive results without major safety issues. Overall, ABA treatments have a strong safety record, particularly in reducing problem behaviors in children.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how ABA-based functional analysis and treatment can help manage problem behaviors in children with Cornelia de Lange Syndrome (CdLS). Unlike typical interventions that might rely on medication or generalized behavioral strategies, this approach is personalized, focusing on understanding the specific triggers and functions of each child's behavior. This tailored technique could lead to more effective and sustainable behavioral improvements, offering new hope for families dealing with the challenges of CdLS.
What evidence suggests that this behavioral therapy is effective for problem behavior in Cornelia de Lange Syndrome?
Research has shown that ABA-based functional analysis, a treatment available in this trial, can reduce problem behaviors in children with Cornelia de Lange Syndrome (CdLS). Early results suggest these treatments can lower problem behaviors by 80% or more from the starting point. Studies have found that children with similar issues, such as those with Autism Spectrum Disorder (ASD), also benefit significantly from this method. The treatment identifies the reasons behind problem behaviors and develops specific strategies to address them. This approach successfully improves behavior by promoting positive actions and reducing negative ones.12678
Who Is on the Research Team?
Patricia F Kurtz, PhD
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Are You a Good Fit for This Trial?
This trial is for English-speaking parents of children aged 3-15 with Cornelia de Lange syndrome (CdLS). It includes those whose children exhibit self-injurious behavior, aggression, or disruptive behavior and can attend clinic visits. Children without these behaviors are in the control group.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Visit Assessments
Parents complete research measures at home and participate in phone interviews to assess child behavior and preferences.
Treatment
Participants attend clinic services for assessment and treatment of problem behaviors, including functional analysis and parent training.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with follow-up visits and phone calls.
Long-term Monitoring (Control Group)
Control group participants are monitored every 3 months for up to 2 years to track the emergence of problem behavior.
What Are the Treatments Tested in This Trial?
Interventions
- ABA-based functional analysis and treatment
ABA-based functional analysis and treatment is already approved in United States, European Union, Canada for the following indications:
- Autism Spectrum Disorder (ASD)
- Behavioral Disorders
- Developmental Disabilities
- Autism Spectrum Disorder (ASD)
- Behavioral Disorders
- Developmental Disabilities
- Autism Spectrum Disorder (ASD)
- Behavioral Disorders
- Developmental Disabilities
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Lead Sponsor